Sector: Health Care
Director information for CRYOPORT INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Daniel M. Hancock | President of DMH Strategic Consulting LLC | 75 | ["43 years of service in GM's powertrain engineering and general management functions","Former Vice President, Global Strategic Product Alliances at GM","Former Chair of GM’s DMAX and VM Motori diesel engine joint ventures","Former Vice President, Global Powertrain Engineering at GM","Former CEO, Fiat-GM Powertrain","Former President, Allison Transmission Division","Chair of the board of SuperTurbo Technologies, Inc.","Advisor to several global suppliers in the automotive and commercial vehicle industries","Former Chair of the Board of Westport Fuel Systems","Past President of SAE International","Member of the National Academy of Engineering","Trustee of the FISITA Foundation","Master's degree in mechanical engineering from MIT","Bachelor's degree in mechanical engineering from General Motors Institute (now Kettering University)"] | ["Audit Committee","Compensation Committee","Scientific and Technology Committee","Science & Technology Committee"] | 2026 |
| Dr. Hariri | Member of the Nomination and Governance Committee; Chair of the Science and Technology Committee | [] | ["Nomination & Governance Committee","Science & Technology Committee"] | 2026 | |
| Dr. Mandalam | Member of the Nomination and Governance Committee | [] | ["Audit Committee","Nomination & Governance Committee","Science & Technology Committee"] | 2026 | |
| Jerrell W. Shelton | Chair, President and Chief Executive Officer | 80 | ["Chair of the Board since October 2015","Former Chair and CEO of Wellness, Inc.","Visiting Executive to IBM Research","Former Chair, President and CEO of NDC Holdings II, Inc.","Former President and CEO of Continental Graphics Holdings, Inc.","Former President and CEO of Thomson Business Information Group","B.S. in Business Administration from the University of Tennessee","M.B.A. from Harvard University"] | [] | 2026 |
| Linda Baddour | Chair of the Board of Directors; Chair of the Nomination and Governance Committee | 67 | ["Senior executive with over twenty years of experience across healthcare, life sciences and pharmaceuticals","Board member of Waters Corporation since 2018","Board member of Signant Health since 2020","Audit committee chair of Waters Corporation","Board member of Zeus, Inc. and Flourish Research since 2025","Board member of Advarra from 2019 until its sale in 2022","Executive Vice President and Chief Financial Officer of PRA Health Sciences, Inc. from 2007 to 2018","Worked at Pharmaceutical Product Development, Inc. from 1995 to 2007","Earned both a B.A. and M.B.A. from the University of North Carolina at Wilmington","CPA-retired","audit committee financial expert"] | ["Nomination and Governance Committee","Audit Committee","Compensation Committee","Nomination & Governance Committee"] | 2026 |
| Ramkumar Mandalam, Ph.D. | Lead Director | 61 | ["Founder and CEO of Citra BioConsulting Inc.","Former CEO, President and board member of Cellerant Therapeutics, Inc.","Former Executive Director of Product Development at Geron Corporation","Various positions in research and development at Aastrom Biosciences","Ph.D. in Chemical Engineering from the University of Michigan"] | ["Compensation Committee","Nomination and Governance Committee","Audit Committee","Science and Technology Committee"] | 2026 |
| Ram M. Jagannath | Global Head of Healthcare | 49 | ["Global Head of Healthcare at Blackstone","Founding Partner of Navab Capital Partners","Managing Director of The Carlyle Group","Experience in healthcare investments","BSE in Biomedical and Electrical Engineering","J.D./MBA from Northwestern University","Fulbright Scholar in Economic Development"] | ["Blackstone Growth Investment Committee","Healthcare Leadership Council","Board of Visitors of the Duke Pratt School of Engineering","Board of Directors of the Navy SEAL Foundation","Kellogg School of Management Private Equity Advisory Council"] | 2026 |
| Robert Hariri, M.D., Ph.D. | Chair of the Scientific and Technology Committee | 66 | ["Visionary surgeon","Scientist","Aviator","Entrepreneur","Founder, Chair and CEO of Celularity, Inc.","Former CEO of the Cellular Therapeutics Division of Celgene Corporation","Founder, Chair and Chief Scientific Officer at Anthrogenesis Corporation","Co-founder of Human Longevity, Inc.","Adjunct Professor of Neurosurgery","Member of the Board of Overseers of the Weill Cornell Medical College","Former member of the Board of Visitors of the Columbia University School of Engineering & Applied Sciences","Member of the X Prize Foundation scientific advisory board","Trustee and vice-chair of the Liberty Science Center","Board member of Myos Corporation","Chair of Bionik Laboratories Corp.","Pioneered the use of stem cells to treat life-threatening diseases","Over 170 issued and pending patents","Authored over 150 published chapters, articles and abstracts"] | ["Scientific and Technology Committee","Nomination and Governance Committee"] | 2026 |
